Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion ⊕
Novo Nordisk said on Thursday it agreed to buy Akero Therapeutics for up to $5.2 billion, giving the Danish drugmaker access to an experimental liver disease drug.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.